AstronauTx-preview

Astronautx

AstronauTx

Private

London, EnglandHealthcare & Life Scienceshttps://www.astronautx.bio

Last Round

Series A

Oct 9, 2023

Total Funding Raised

$70.17M

Momentum Score

75 /100

Company Overview

AstronauTx is a biotechnology company focused on developing innovative treatments for Alzheimer's disease and other neurodegenerative disorders.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery, Clinical Trials

Business Model

B2B

Customer Profile

Government Contracts, Services & Consulting

AI Layer

Non-AI

Keywords

astrocyte modulationAlzheimer's treatmentsmall molecule drugsneurodegenerative diseasedrug discoverydisease-modifying therapypreclinical biotechneurotherapeuticsastrocyte biologydrug pipelinepharma partnershipsclinical trials

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

AstronauTx Comps

Public and private peers based on sector, stage, and business model.

Company	Status	Est. Valuation	Rev Multiple
OpenAI	Private	$86.0B	~40x
Cohere	Private	$5.0B	--
Competitor 1	Public	$XX.XB	XXx
Competitor 2	Public	$XX.XB	XXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

AstronauTx Funding Rounds

Historical fundraising activity

Round	Date	Amount Raised	Valuation	Investors	Sources
Series A	Oct 9, 2023
Grant	Sep 1, 2023
Seed	Mar 24, 2020
Seed	Aug 12, 2019

View all Funding Rounds

Key People

Founding team and executive leadership

Hannah Pearce

Chief Operating Officer

Executive Team

AstronauTx Investors

Notable investors and investment history

Investor	Rounds
Innovate UK	Grant
MPM Capital	Series A
EQT Life Sciences	Series A
UKRI Innovate UK	Grant
Brandon Capital	Series A

View all Investors

Market signals

Structured signals derived from secondary market and firmographic data.

Jan 7, 2026
Adam Rosenberg appointed as Chair of the Board of Directors.

View all signals

AstronauTx Filings

SEC and related filings with document metadata.

Typed	Date	Amount Offered	Amount Sold	Filling	Pages	Download
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation

AstronauTx Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about AstronauTx's valuation, stock price, and market status.

Firmographic Details

HeadquartersLondon, England

Employee Range19

Year Founded2019

Last FundingOct 9, 2023

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.